Marty Nazzaro
Chief Operating Officer at Inflammasome Therapeutics, Inc.
Marty Nazzaro active positions
| Companies | Position | Start | End |
|---|---|---|---|
Inflammasome Therapeutics, Inc.
 Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Chief Operating Officer | 2020-02-29 | - |
Career history of Marty Nazzaro
Former positions of Marty Nazzaro
| Companies | Position | Start | End |
|---|---|---|---|
Control Delivery Systems, Inc.
 Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Corporate Officer/Principal | - | - |
| EYEPOINT PHARMACEUTICALS, INC. | Chief Operating Officer | 2006-04-30 | - |
| Corporate Officer/Principal | 2009-10-18 | 2009-10-18 |
Training of Marty Nazzaro
| Suffolk University | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Australia | 2 |
Operational
| Chief Operating Officer | 2 |
| Corporate Officer/Principal | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| EYEPOINT PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Control Delivery Systems, Inc.
Control Delivery Systems, Inc. Medical SpecialtiesHealth Technology Control Delivery Systems Inc. designs, develops and manufactures drug delivery products. The products are designed to deliver precise quantities of drugs to difficult-to-treat areas of the body. The company was founded in 1991 and is headquartered in Watertown, MA. | Health Technology |
Inflammasome Therapeutics, Inc.
Inflammasome Therapeutics, Inc. BiotechnologyHealth Technology Inflammasome Therapeutics, Inc. develops therapies for prevalent and degenerative diseases. The American company was founded in 2016 by Jayakrishna Ambati and Paul Ashton. Paul Ashton has been the CEO since 2016. | Health Technology |
- Stock Market
- Insiders
- Marty Nazzaro
- Experience
